Published in Cancer on May 15, 1999
Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value. World J Gastroenterol (2014) 0.92
Invasive squamous cell carcinoma of the eyelids and periorbital region. Br J Ophthalmol (2006) 0.91
Histological grading in gastric cancer by Ming classification: correlation with histopathological subtypes, metastasis, and prognosis. World J Surg (2005) 0.85
A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis. Virchows Arch (2009) 0.82
Prognostic value of Goseki histological classification in adenocarcinoma of the cardia. Br J Cancer (2003) 0.80
Relationships between mucinous gastric carcinoma, MUC2 expression and survival. World J Gastroenterol (2006) 0.80
Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging. Cancer (2000) 0.75
Association between genetic polymorphisms in cortactin and susceptibility to gastric cancer. Ann Surg Treat Res (2015) 0.75
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med (2001) 13.75
Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet (1995) 7.64
Extended lymph-node dissection for gastric cancer. N Engl J Med (1999) 7.43
Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol (2001) 6.30
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med (1993) 6.13
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol (2012) 5.32
Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol (2001) 5.28
Micrometastases and survival in stage II colorectal cancer. N Engl J Med (1998) 5.11
Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med (1987) 4.55
Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int (1998) 4.31
Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature (2001) 3.99
Pressure sores and pressure-decreasing mattresses: controlled clinical trial. Lancet (1994) 3.70
Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet (1994) 3.69
Complications of laparoscopy: a prospective multicentre observational study. Br J Obstet Gynaecol (1997) 3.57
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol (1993) 3.56
Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet (1994) 3.45
A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem (1993) 3.41
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med (1999) 3.22
[Autopsy are a useful quality instrument because of unexpected clinical relevant findings and the answering of clinical questions; a retrospective study]. Ned Tijdschr Geneeskd (2003) 3.17
[Diversity of complaints in manifesting carcinoma of the gallbladder]. Ned Tijdschr Geneeskd (2007) 3.10
Hydrophilicity of cavities in proteins. Proteins (1996) 3.09
Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol (1995) 3.06
Diagnostic value of an immunoassay to detect anti Campylobacter pylori antibodies in non-ulcer dyspepsia. Lancet (1989) 3.03
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res (2001) 3.02
Glutamine and the preservation of gut integrity. Lancet (1993) 2.72
An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol (1994) 2.67
Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver. J Pathol (1999) 2.57
Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res (1993) 2.39
Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut (1998) 2.38
Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet (2001) 2.35
Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. Pediatrics (1994) 2.33
In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother (1998) 2.32
Assembly of fibrin. A light scattering study. J Biol Chem (1979) 2.31
Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis. Lancet (1996) 2.30
K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res (1996) 2.29
Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int (1999) 2.26
Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res (1998) 2.23
Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis. Gastroenterology (1994) 2.22
No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol (2001) 2.20
Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg (1996) 2.15
A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J Biol Chem (1999) 2.15
Size and density of fibrin fibers from turbidity. Macromolecules (1978) 2.12
Desmoid tumours in familial adenomatous polyposis. Gut (1994) 2.08
[Entering of patients in clinical-oncological trials: why not exclusive exclusion when inclusion is out of the question?]. Ned Tijdschr Geneeskd (1995) 2.03
Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative. Ital J Gastroenterol Hepatol (1999) 2.02
The value of morphometry to classic prognosticators in breast cancer. Cancer (1985) 2.00
Helicobacter pylori and gastric carcinoma. Histopathology (1990) 1.98
Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res (2001) 1.98
Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut (1992) 1.96
Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. Lancet (2000) 1.95
Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid. Am J Pathol (1993) 1.91
Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment. Lancet (1987) 1.90
Identification of virilizing adrenal tumors in hirsute women. N Engl J Med (1994) 1.90
Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg (1996) 1.90
Temporary decompression after colorectal surgery: randomized comparison of loop ileostomy and loop colostomy. Br J Surg (1998) 1.88
Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc (1997) 1.88
Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value. Br J Cancer (2001) 1.88
Time trends in gastric carcinoma: changing patterns of type and location. Am J Gastroenterol (1992) 1.88
Evaluation of the feasibility, reliability and diagnostic value of shortened versions of the geriatric depression scale. Br J Gen Pract (1995) 1.86
Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut (1993) 1.85
Mechanisms of oncogenesis in colon versus rectal cancer. J Pathol (2001) 1.83
Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation. Gut (1994) 1.82
Colorectal neoplasia in juvenile polyposis or juvenile polyps. Arch Dis Child (1991) 1.81
Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene (1991) 1.81
In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53. Eur J Immunol (1993) 1.79
Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol (1994) 1.79
Antibody phage display technology and its applications. Immunotechnology (1998) 1.79
Pharmacokinetics of brotizolam in healthy subjects following intravenous and oral administration. Br J Clin Pharmacol (1983) 1.78
Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med (1987) 1.76
Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis. Gastroenterology (1988) 1.75
Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion (1997) 1.75
Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg (1994) 1.74
Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum (2000) 1.74
Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis. Dutch Pentasa Study Group. Eur J Gastroenterol Hepatol (1995) 1.74
Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection. Digestion (1989) 1.73
Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res (1998) 1.73
Influence of abdominal-wound closure technique on complications after surgery: a randomised study. Lancet (1999) 1.73
A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer (1988) 1.72
Leptin is a growth factor for colonic epithelial cells. Gastroenterology (2001) 1.71
Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer (1996) 1.71
Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer. J Clin Pathol (1987) 1.71
Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol (2000) 1.69
Computer simulation of the dynamics of hydrated protein crystals and its comparison with x-ray data. Proc Natl Acad Sci U S A (1983) 1.69